ALTEX Archive - 3/12


Editorial
Sonja von Aulock

Contents

FOOD FOR THOUGHT

Thomas Hartung and Joanne Zurlo
Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare

MAIN ARTICLES
Stefan Schildknecht, Susanne Kirner, Anja Henn, Karlo Gasparic, Regina Pape, Liudmila Efremova, Olaf Maier, Roman Fischer, and Marcel Leist
Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions

Fransisca Leonard, Hussain Ali, Eva-Maria Collnot, Bart J. Crielaard, Twan Lammers, Gert Storm, and Claus-Michael Lehr
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model 

Marie-Jeanne W. A. Schiffelers, Bas J. Blaauboer, Coenraad F. M. Hendriksen, and Wieger E. Bakker
Regulatory acceptance and use of 3R models: a multilevel perspective

Kristina Wagner, Bettina Fach, and Roman Kolar
Inconsistencies in data requirements of EU legislation involving tests on animals

CONFERENCE REPORTS
Elizabeth Stallman Brown, Abigail Jacobs, and Suzanne Fitzpatrick
Reproductive and developmental toxicity testing: from in vivo to in vitro

CORNERS

ASCCT
CAATfeed
ICCVAM/NICEATM
IIVS

NEWS
AUT: Encyclopedia on animal ethics and animal welfare established
CHN: China poised to accept first non-animal test method for cosmetics
EU: Results of stakeholder questionnaire on QSAR models for REACH
EU: ECVAM Search Guide as free pdf
GER: Three awards for alternative methods open for application
GER: Animal protection organizations appeal for highest standard in new animal protection law
IND: Alternatives session at medical students’ forum
IND: Tenth in vitro toxicology workshop at MGDC
INT: www.humane-endpoints.info: free educational website open
SUI: ALTEX Award 2012 for Erwin van Vliet
SUI: ALTEX impact factor steady at 4.4
UK: LUSH prize for replacement of animal tests
UK: Call for NC3Rs studentships
USA: Reduction of animal numbers for potency test of tuberculin an option

INSTRUCTIONS

CALENDAR

IMPRINT

COVER


Nach oben